The number of people with susceptibility test result for rifampicin in Grenada
Grenada: The number of people with susceptibility test result for rifampicin was 0 in 2021. ◆ Volatile
Latest (2021)
0
World rank
142nd
of 146 countries
All-time high
100
in 2019
All-time low
0
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Grenada, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Grenada is 0, measured in 2021. That is the lowest value across all 5 years on record.
That places Grenada 142nd out of 146 countries with data for 2021, putting it in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Grenada, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 100 | — |
| 2020 | 0 | -100.0% |
| 2021 | 0 | — |
Grenada compared with similar countries
- Grenada's 0 is below the median for upper middle income countries, which is 92.7. (45 countries reporting)
- Grenada's 0 is below the median for Latin America & Caribbean, which is 59.38. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 33.33 | 0 | 100 | 3 |
| 2020s | 0 | 0 | 0 | 2 |
Countries ranked near Grenada
- 139 Central African Republic 9.75 compare
- 140 Venezuela, Bolivarian Republic of 3.31 compare
- 141 France 1.45 compare
- 142 South Sudan 0 compare
- 142 Sao Tome and Principe 0 compare
- 142 Vanuatu 0 compare
- 142 Mauritania 0 compare
More health data for Grenada
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0116 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,727 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.69 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0283 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.65 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Grenada?
- The number of people with susceptibility test result for rifampicin in Grenada was 0 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Grenada?
- The highest recorded value was 100 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Grenada?
- The lowest recorded value was 0 in 2017.
- How does Grenada rank for the number of people with susceptibility test result for rifampicin?
- Grenada ranks 142nd out of 146 countries with data for 2021.
- Where does this Grenada data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).